MediciNova, Inc.
Notice of Change in Major Shareholders
Announcement of a change in major shareholders. Following the filing of Schedule 13D/A, 3D Investment Partners Private Limited's ownership fell below 10%, and it no longer qualifies as a major shareholder. There is no direct impact expected on future performance. Voting rights decreased from 5,502,047 shares (11.18%) before the change to 4,862,047 shares (9.88%) after the change.
Key Figures
- Number of voting rights: Before change 5,502,047 shares → After change 4,862,047 shares
- Percentage of voting rights: Before change 11.18% → After change 9.88%
- Announcement date: 2026-09-29
AI要約
Summary of the News
US-based clinical-stage company MediciNova, Inc. announced a change in major shareholders on September 29, 2026. With the filing of Schedule 13D/A, 3D Investment Partners Private Limited's percentage of voting rights fell below 10%, and it ceased to be a major shareholder. Voting rights before and after the change were 5,502,047 shares (11.18%) and 4,862,047 shares (9.88%), respectively. The company states there is no impact on future financial results.
Impact and Outlook
This shareholder change is limited to a shift in voting rights percentage and does not constitute dilution of capital or a change in control. The company continues to advance key development candidates such as MN-166 and MN-001; monitoring of funding sources and clinical development timing remains necessary, but no immediate impact on operating performance has been indicated.
MediciNova, Inc.
Company overview · Stock price · Financial data · All IR
